ADELMAN DANIEL C MD

CIK 00012220372 companiesBRISBANE, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001222037

Recent Transactions

45 trades

Disposition to Issuer
Aimmune Therapeutics, Inc.
Stock Option (right to buy)
2020-10-13$0.43/sh−56,250→ 0 total
Disposition to Issuer
Aimmune Therapeutics, Inc.
Stock Option (right to buy)
2020-10-13$14.87/sh−70,000→ 0 total
Disposition to Issuer
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2020-10-13$34.50/sh−22,343→ 0 total
Disposition to Issuer
Aimmune Therapeutics, Inc.
Stock Option (right to buy)
2020-10-13$23.05/sh−135,068→ 0 total
Disposition to Issuer
Aimmune Therapeutics, Inc.
Stock Option (right to buy)
2020-10-13$10.78/sh−71,250→ 0 total
Disposition to Issuer
Aimmune Therapeutics, Inc.
Stock Option (right to buy)
2020-10-13$10.69/sh−52,500→ 0 total
Disposition from Tender
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2020-10-10$34.50/sh−41,464→ 0 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Stock Option (Right to Buy)
2020-10-02−34,932→ 135,068 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2020-10-02$11.45/sh+34,932→ 63,807 total
Tax Payment
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2020-09-15$34.25/sh−840→ 28,875 total
Award
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2020-05-10+2,420→ 29,715 total
Tax Payment
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2020-03-02$23.81/sh−1,872→ 27,295 total
Award
Aimmune Therapeutics, Inc.
Stock Option (right to buy)
2020-02-28+52,500→ 52,500 total
Award
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2020-02-28+8,750→ 29,167 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2020-01-02$19.63/sh+20,000→ 41,250 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Stock Option (right to buy)
2020-01-02−20,000→ 70,000 total
Sale
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2020-01-02$35.00/sh−20,000→ 21,250 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2019-12-09$11.45/sh+20,000→ 41,250 total
Sale
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2019-12-09$30.04/sh−20,000→ 21,250 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Stock Option (right to buy)
2019-12-09−20,000→ 170,000 total
Tax Payment
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2019-03-01$24.30/sh−833→ 20,417 total
Award
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2019-02-22+11,875→ 21,250 total
Award
Aimmune Therapeutics, Inc.
Stock Option (right to buy)
2019-02-22+71,250→ 71,250 total
Award
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2018-03-04+9,375→ 9,375 total
Award
Aimmune Therapeutics, Inc.
Stock Option(right to buy)
2018-03-04+56,250→ 56,250 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Stock Option (right to buy)
2018-01-16−9,933→ 190,000 total
Sale
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2018-01-16$40.00/sh−9,933→ 0 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2018-01-16$11.45/sh+9,933→ 9,933 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2018-01-12$11.45/sh+26,784→ 26,784 total
Sale
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2018-01-12$40.00/sh−26,784→ 0 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Stock Option (right to buy)
2018-01-12−26,784→ 199,933 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2017-12-27$11.45/sh+3,283→ 3,283 total
Sale
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2017-12-27$40.00/sh−3,283→ 0 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Stock Option(right to buy)
2017-12-27−3,283→ 226,717 total
Sale
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2017-10-23$34.27/sh−1,470→ 3,000 total
Sale
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2017-10-23$33.25/sh−5,530→ 4,470 total
Sale
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2017-10-23$35.46/sh−3,000→ 0 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2017-10-23$11.45/sh+10,000→ 10,000 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Stock Option (right to buy)
2017-10-23−10,000→ 230,000 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2017-09-25$11.45/sh+10,000→ 10,000 total
Sale
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2017-09-25$25.00/sh−10,000→ 0 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Stock Option (right to buy)
2017-09-25−10,000→ 240,000 total
Award
Aimmune Therapeutics, Inc.
Stock Option (right to buy)
2017-02-24+90,000→ 90,000 total
Award
Aimmune Therapeutics, Inc.
Stock Option (right to buy)
2016-06-24+250,000→ 250,000 total
Award
Viracta Therapeutics, Inc.$VIRX
Employee Stock Option (right to buy)
2007-09-13+90,000→ 90,000 total

Companies

Recent Filings

Address

AIMMUNE THERAPEUTICS, INC. 8000 MARINA BOULEVARD, SUITE 300

BRISBANE, CA, 94005-1884

View on SEC.gov